Pfizer Korea wins lawsuit over Lyrica patent dispute

Published: 2013-10-14 06:59:00
Updated: 2013-10-14 06:59:00
Pfizer Korea scored another victory in its Lyrica (Pregabalin) patent dispute against Korean generic drug manufacturers, following the court ruling against CJ Cheil Jedang in May.

The Patent Court of Korea ruled that generic firms had infringed on Pfizer’s patent of Lyrica, which is used to tr...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.